Menlo Park, United States
Inquis Medical, Inc. is a clinical stage medical device company based in the innovation hub of Silicon Valley. Founded in 2019, this privately-held company is committed to revolutionizing the field of venous thromboembolic disease management through its proprietary, next-generation thrombectomy technology. The technology stands out for its ability to perform efficient single-pass thrombectomy procedures with minimal blood loss, addressing a significant unmet need in healthcare.
With a legacy of developing physician-tested medical devices, Inquis Medical, Inc. has positioned itself at the forefront of the health care industry. The company's innovative approach offers investors a unique opportunity to participate in a sector driven by continuous advancements and demand for effective health solutions.
The company last received a Venture Round investment on 01 January 2022, with funding from Yu Galaxy. This investment highlights confidence in the company's potential to deliver substantial returns by addressing critical health issues.
